Atlas Trials

Risk of Tuberculous and Other Infections in Patients of Spondyloarthritis Treated With Tofacitinib in Bangladesh

Clinical trial NCT03504072 · UNKNOWN

Trial details

NCT number
NCT03504072
Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Spondyloarthritis
Start date
2018-01-16
Primary completion
2019-06-30
Enrollment
174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.